These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9474258)

  • 21. [The new nonsteroidal anti-inflammatory preparation meloxicam in the treatment of rheumatoid arthritis].
    Grishina EI
    Lik Sprava; 1997; (2):19-25. PubMed ID: 9333474
    [No Abstract]   [Full Text] [Related]  

  • 22. [The use of non-steroidal anti inflammatory drugs (NSAIDs)--COX-2 inhibitors].
    Tishler M; Langevetiz P; Nesher G
    Harefuah; 2002 Oct; 141(10):920-1. PubMed ID: 12420601
    [No Abstract]   [Full Text] [Related]  

  • 23. Celecoxib for the treatment of pain and inflammation: the preclinical and clinical results.
    Tindall E
    J Am Osteopath Assoc; 1999 Nov; 99(11 Suppl):S13-7. PubMed ID: 10643176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meloxicam-induced liver toxicity.
    Staerkel P; Horsmans Y
    Acta Gastroenterol Belg; 1999; 62(2):255-6. PubMed ID: 10427794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cox-2 inhibitors.
    Strassels S
    J Mass Dent Soc; 1999; 48(3):43-4. PubMed ID: 10808349
    [No Abstract]   [Full Text] [Related]  

  • 26. [The cardiovascular safety of cyclooxygenase-2 (COX-2) inhibitors].
    Hasdai D; Gottlieb S; Godbourt U; Hod H; Kaluski E
    Harefuah; 2002 Oct; 141(10):922-4. PubMed ID: 12420602
    [No Abstract]   [Full Text] [Related]  

  • 27. Third International Meeting on Cyclooxygenase-2--basic research and therapeutic use, Regensburg, Germany, June 7-8, 2002.
    Krämer BK
    Nephrol Dial Transplant; 2003 Mar; 18(3):477-8. PubMed ID: 12584266
    [No Abstract]   [Full Text] [Related]  

  • 28. COX-1, COX-2, and COX-3 and the future treatment of chronic inflammatory disease.
    Willoughby DA; Moore AR; Colville-Nash PR
    Lancet; 2000 Feb; 355(9204):646-8. PubMed ID: 10696997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meloxicam in rheumatoid arthritis.
    Ahmed M; Khanna D; Furst DE
    Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):739-51. PubMed ID: 16863437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Meloxicam (Mobic): a review of its pharmacological and clinical profile].
    Ogino K; Saito K; Osugi T; Satoh H
    Nihon Yakurigaku Zasshi; 2002 Dec; 120(6):391-7. PubMed ID: 12528470
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclooxygenase-2 inhibition and cardiovascular events.
    Pitt B; Pepine C; Willerson JT
    Circulation; 2002 Jul; 106(2):167-9. PubMed ID: 12105151
    [No Abstract]   [Full Text] [Related]  

  • 32. [Specific COX-2 inhibitors. Also effective in arthritis?].
    Einecke D
    MMW Fortschr Med; 2000 Jan; 142(3):10. PubMed ID: 10726454
    [No Abstract]   [Full Text] [Related]  

  • 33. [COX-2--what are the clinical implications?].
    Lipsky PE
    Nihon Rinsho Meneki Gakkai Kaishi; 2000 Dec; 23(6):679-82. PubMed ID: 11210769
    [No Abstract]   [Full Text] [Related]  

  • 34. [New aspects of anti-inflammatory therapy of rheumatic diseases: preclinical validation and clinical trial of meloxicam].
    Nasonov EL; Tsvetkova ES; Balabanova RM; Denisov LN; Alekseeva LI; Nasonova VA
    Klin Med (Mosk); 1996; 74(4):4-8. PubMed ID: 8999152
    [No Abstract]   [Full Text] [Related]  

  • 35. The future of NSAID therapy: selective COX-2 inhibitors.
    Vane JR; Botting RM
    Int J Clin Pract; 2000; 54(1):7-9. PubMed ID: 10750251
    [No Abstract]   [Full Text] [Related]  

  • 36. Evaluation of meloxicam (A cox-2 inhibitor) for management of postoperative endodontic pain: a double-blind placebo-controlled study.
    Nekoofar MH; Sadeghipanah M; Dehpour AR
    J Endod; 2003 Oct; 29(10):634-7. PubMed ID: 14606784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COX-2 inhibitors: better than ibuprofen for dental pain?
    Dionne R
    Compend Contin Educ Dent; 1999 Jun; 20(6):518-20, 522-4. PubMed ID: 10650365
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective Cox-2 inhibition in man-therapeutic breakthrough or cosmetic advance?
    Wollheim FA
    Rheumatology (Oxford); 2000 Sep; 39(9):935-8. PubMed ID: 10986296
    [No Abstract]   [Full Text] [Related]  

  • 39. Meloxicam inhibits prostaglandin E(2) generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach.
    Ogino K; Hatanaka K; Kawamura M; Ohno T; Harada Y
    Pharmacology; 2000 Nov; 61(4):244-50. PubMed ID: 11093076
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical use of COX-2 inhibitors].
    Ristić GG; Stefanović DZ
    Vojnosanit Pregl; 2001; 58(3):283-95. PubMed ID: 11548555
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.